Generic Semaglutide Surge Reshapes India’s Obesity Drug Market
A Rapid Shift in Market Dynamics Torrent Pharmaceuticals has captured a significant 38% market share in India’s burgeoning semaglutide sector, signaling a major shift in the accessibility of GLP-1 receptor agonists. As of late 2024, the entrance of cost-effective generic alternatives has caused the Indian market for these obesity treatments to expand tenfold, challenging the…